AustraliaWorld Eisai Says Alzheimer’s Drug Will Get Priority Review in UnitedStates By australianadmin July 6, 2022July 6, 2022 0 minutes, 7 seconds Read Eisai Co. stated its speculative Alzheimer’s drug lecanemab will get a concern evaluation by the U.S. Food and Drug Administration.Read More.
Australia Mall staple Forever 21 files for bankruptcy protection, again By australianadmin March 17, 2025March 17, 2025
Australia Heartbreak as Aussie Logan Martin missesouton out on a medal in BMX last By Romeo Peter August 1, 2024August 1, 2024